Savara Pharmaceuticals
SVRA
#6617
Rank
C$0.79 B
Marketcap
$4.61
Share price
-1.23%
Change (1 day)
-25.09%
Change (1 year)

Earnings for Savara Pharmaceuticals (SVRA)

Earnings in 2024 (TTM): -C$0.12 Billion

According to Savara Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -C$78.33 Million a decrease over its 2022 earnings that were of -C$54.64 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Savara Pharmaceuticals from 2002 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -C$0.12 Billion43.14%
2023 -C$78.33 Million43.38%
2022 -C$54.64 Million-11.31%
2021 -C$61.6 Million-13.3%
2020 -C$71.05 Million-36.53%
2019 -C$0.12 Billion13.76%
2018 -C$98.41 Million105.54%
2017 -C$47.88 Million34.11%
2016 -C$35.7 Million-37.43%
2015 -C$57.06 Million38.81%
2014 -C$41.11 Million33.62%
2013 -C$30.76 Million38.49%
2012 -C$22.22 Million24.59%
2011 -C$17.83 Million-36.5%
2010 -C$28.08 Million-3.14%
2009 -C$28.99 Million-23.28%
2008 -C$37.78 Million8.52%
2007 -C$34.82 Million-34.14%
2006 -C$52.87 Million184.43%
2005 -C$18.59 Million90.75%
2004 -C$9.75 Million190.35%
2003 -C$3.36 Million11.64%
2002 -C$3.01 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-C$26 Million-78.11%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$0.17 Billion 42.09%๐Ÿ‡บ๐Ÿ‡ธ USA